Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southern XP Pharmaceuticals
Sydney, New South Wales, Australiasouthernxp.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Southern XP Pharmaceuticals is an Australian-based pharmaceutical company focused on the development of improved formulations of existing pain management medications. The company specializes in creating value-added generic products using proprietary formulation technologies to enhance the safety and efficacy profiles of established drugs. Its lead programs involve optimized delivery systems for opioid analgesics designed to provide rapid onset of action while potentially reducing side effects. Southern XP primarily targets the global pain management market through strategic clinical development and regulatory pathways.
- Therapeutic areas
- Neurology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Southern XP Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Southern XP Pharmaceuticals.